Search Result

Pathways Recommended:	MAPK/ERK Pathway

Results for "

p44 MAPK

" in MedChemExpress (MCE) Product Catalog:

By Targets:	p38 MAPK (3) AMPK (1) Angiotensin Receptor (2) Apoptosis (4) Caspase (1) Estrogen Receptor/ERR (1) Ferroptosis (1) GSK-3 (1) HSP (1) JAK (1) LPL Receptor (5) MDM-2/p53 (1) Neuropeptide Y Receptor (3) NF-κB (2) Reference Standards (2) Small Interfering RNA (siRNA) (3) STAT (1) TNF Receptor (3) YAP (2)
By Research Areas:	Cancer (5) Cardiovascular Disease (2) Endocrinology (4) Inflammation/Immunology (2) Metabolic Disease (4) Neurological Disease (10)
Oligonucleotides:	Rat Pre-designed siRNA Sets (1) Mouse Pre-designed siRNA Sets (1) Human Pre-designed siRNA Sets (1) siRNAs (3)

Inhibitors & Agonists

Recombinant Proteins

Antibodies

Oligonucleotides

Targets Recommended: p38 MAPK MAP4K MAPKAPK2 (MK2) MNK

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-13285

Ki16425 Maximum Cited Publications 11 Publications Verification Debio 0719	LPL Receptor YAP	Neurological Disease Cancer
Ki16425 (Debio 0719) is a subtype-selective, competitive antagonist of the EDG-family receptors, LPA1 and LPA3 with K_is of 0.34 μM and 0.93 μM, respectively. Ki16425 (Debio 0719) reduces the LPA-induced activation of p42/p44 MAPK . Ki16425 can also inhibit LPA-induced dephosphorylation of Yes-associated protein (YAP)/TAZ in HEK293A cells .

HY-13106

Olodanrigan 4 Publications Verification EMA401; PD-126055; (S)-EMA400	Angiotensin Receptor	Cardiovascular Disease Neurological Disease Endocrinology
Olodanrigan (EMA401) is a highly selective, orally active, peripherally restricted angiotensin II type 2 receptor (AT2R) antagonist. It is under development as a neuropathic pain therapeutic agent. Olodanrigan (EMA401) analgesic action appears to involve inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons .

HY-101986

BIIE-0246 2 Publications Verification AR-H 053591	Neuropeptide Y Receptor	Metabolic Disease Endocrinology
BIIE-0246 (AR-H 053591) is a potent and selective NPY2R (neuropeptide Y receptor 2) antagonist with an IC₅₀ value of 15 nM for rat [ ¹²⁵I]PYY_3-36. BIIE-0246 decreases the expression of p-AKT S473, P-p44/42 MAPK under the NPY-stimulated. BIIE-0246 reduces albuminuria in ADR nephropathy .

HY-10968

CYM5442 3 Publications Verification	LPL Receptor	Neurological Disease
CYM5442 is a potent, highly-selective and orally active sphingosine 1-phosphate (S1P1) receptor agonist with an EC₅₀ of 1.35 nM. CYM5442 is inactive against S1P2, S1P3, S1P4, and S1P5. CYM5442 activates S1P1-dependent p42/p44-MAPK phosphorylation. CYM5442 exerts retinal neuroprotection. CYM5442 can easily penetrate the central nervous system (CNS) .

HY-19667A

BMS-561392 formate 2 Publications Verification DPC 333 formate	TNF Receptor NF-κB Apoptosis p38 MAPK	Neurological Disease Inflammation/Immunology
BMS-561392 formate (DPC 333 formate) is a selective ADAM17(TACE) inhibitor. BMS-561392 formate inhibits TNF-α secretion by regulating signaling pathways such as **p44 MAPK and NF-κB. BMS-561392 formate also affects the survival of central nervous system-related cells including oligodendrocytes and microglia. BMS-561392 formate promotes microglial apoptosis**, enlarges the injury area and exacerbates astrogliosis in a mouse spinal cord injury model. BMS-561392 formate can be used in research related to spinal cord injury and inflammatory diseases .

HY-168894

CT-1	Ferroptosis JAK STAT p38 MAPK AMPK GSK-3 Apoptosis HSP TNF Receptor	Cardiovascular Disease Neurological Disease Metabolic Disease Cancer
CT-1 is a secreted protein belonging to the IL-6 cytokine family. Overexpression of CT-1 enhances cell proliferation, migration and angiogenesis via the ADMA/DDAH pathway. CT-1 inhibits the growth of triple-negative breast cancer cells by simultaneously inducing Ferroptosis in N2-type tumor-associated neutrophils and cancer cells. CT-1 activates the Jak/STAT-3, *p42/p44* *MAPK* and AMPK pathways, and inhibits GSK-3β activity through phosphorylation to induce cardiomyocyte hypertrophy. CT-1 enhances the viability of cardiomyocytes and neurons, reduces cell Apoptosis, induces the expression of heat shock proteins (HSP) and BNP, and inhibits TNF levels. CT-1 exerts anti-tumor activity in mouse models of triple-negative breast cancer. CT-1 improves cognitive impairment in mice. CT-1 is applicable to the research of ischemic heart disease, triple-negative breast cancer, myocardial hypertrophy, Parkinson's disease, hypertensive heart disease, myocardial infarction, acute Chagas cardiomyopathy, high-fat diet-induced cognitive impairment and diabetes-related cognitive impairment .

HY-19667

BMS-561392 DPC 333	TNF Receptor NF-κB Apoptosis p38 MAPK	Neurological Disease Inflammation/Immunology
BMS-561392 (BMS-561392) is a selective ADAM17(TACE) inhibitor. BMS-561392 inhibits TNF-α secretion by regulating signaling pathways such as **p44 MAPK and NF-κB. BMS-561392 also affects the survival of central nervous system-related cells including oligodendrocytes and microglia. BMS-561392 promotes microglial apoptosis**, enlarges the injury area and exacerbates astrogliosis in a mouse spinal cord injury model. BMS-561392 can be used in research related to spinal cord injury and inflammatory diseases .

HY-13106A

Olodanrigan sodium EMA401 sodium; PD-126055 sodium	Angiotensin Receptor	Neurological Disease Endocrinology
Olodanrigan (EMA401) sodium is a highly selective, orally active, peripherally restricted angiotensin II type 2 receptor (AT2R) antagonist. Olodanrigan sodium is under development as a neuropathic pain therapeutic agent. Olodanrigan sodium analgesic action appears to involve inhibition of augmented AngII/AT2R induced p38 and p42/p44 MAPK activation, and hence inhibition of DRG neuron hyperexcitability and sprouting of DRG neurons .

HY-10968A

CYM5442 hydrochloride	LPL Receptor	Neurological Disease
CYM5442 hydrochloride is a potent, highly-selective and orally active sphingosine 1-phosphate (S1P1) receptor agonist with an EC₅₀ of 1.35 nM. CYM5442 hydrochloride is inactive against S1P2, S1P3, S1P4, and S1P5. CYM5442 hydrochloride activates S1P1-dependent p42/p44-MAPK phosphorylation. CYM5442 exerts retinal neuroprotection. CYM5442 hydrochloride can easily penetrate the central nervous system (CNS) .

HY-101986A

BIIE-0246 hydrochloride 2 Publications Verification AR-H 053591 hydrochloride	Neuropeptide Y Receptor	Metabolic Disease
BIIE-0246 hydrochloride (AR-H 053591 hydrochloride) is a potent and selective NPY2R (neuropeptide Y receptor 2) antagonist with an IC₅₀ value of 15 nM for rat [ ¹²⁵I]PYY_3-36. BIIE-0246 hydrochloride decreases the expression of p-AKT S473, P-p44/42 MAPK under the NPY-stimulated. BIIE-0246 hydrochloride reduces albuminuria in ADR nephropathy .

HY-13285R

Ki16425 (Standard) Debio 0719 (Standard)	LPL Receptor YAP Reference Standards	Neurological Disease Cancer
Ki16425 (Standard) is the analytical standard of Ki16425. This product is intended for research and analytical applications. Ki16425 (Debio 0719) is a subtype-selective, competitive antagonist of the EDG-family receptors, LPA1 and LPA3 with Kis of 0.34 μM and 0.93 μM, respectively. Ki16425 (Debio 0719) reduces the LPA-induced activation of p42/p44 MAPK . Ki16425 can also inhibit LPA-induced dephosphorylation of Yes-associated protein (YAP)/TAZ in HEK293A cells .

HY-10968R

CYM5442 (Standard)	LPL Receptor	Neurological Disease
CYM5442 (Standard) is the analytical standard of CYM5442. This product is intended for research and analytical applications. CYM5442 is a potent, highly-selective and orally active sphingosine 1-phosphate (S1P1) receptor agonist with an EC50 of 1.35 nM. CYM5442 is inactive against S1P2, S1P3, S1P4, and S1P5. CYM5442 activates S1P1-dependent p42/p44-MAPK phosphorylation. CYM5442 exerts retinal neuroprotection. CYM5442 can easily penetrate the central nervous system (CNS) .

HY-177011

ERRγ-IN-1	Estrogen Receptor/ERR	Cancer
ERRγ-IN-1 is a ERRγ inhibitor with an IC₅₀ of 0.040 μM. ERRγ-IN-1 activates **MAPK (p44/p42) and inhibits the activity of ERRγ**. ERRγ-IN-1 significantly increases iodine uptake in anaplastic thyroid carcinoma xenografts and suppresses tumor growth in nude mice. ERRγ-IN-1 is applicable for the research of anaplastic thyroid carcinoma .

HY-RS08113

MAPK3 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
MAPK3 Human Pre-designed siRNA Set A contains three designed siRNAs for MAPK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAPK3 Human Pre-designed siRNA Set A MAPK3 Human Pre-designed siRNA Set A

HY-101986R

BIIE-0246 (Standard) AR-H 053591 (Standard)	Reference Standards Neuropeptide Y Receptor	Metabolic Disease Endocrinology
BIIE-0246 (Standard) is the analytical standard of BIIE-0246 (HY-101986). This product is intended for research and analytical applications. BIIE-0246 (AR-H 053591) is a potent and selective NPY2R (neuropeptide Y receptor 2) antagonist with an IC₅₀ value of 15 nM for rat [125I]PYY3-36. BIIE-0246 decreases the expression of p-AKT S473, P-p44/42 MAPK under the NPY-stimulated. BIIE-0246 reduces albuminuria in ADR nephropathy .

HY-RS08114

Mapk3 Mouse Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Mapk3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mapk3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mapk3 Mouse Pre-designed siRNA Set A Mapk3 Mouse Pre-designed siRNA Set A

HY-RS08115

Mapk3 Rat Pre-designed siRNA Set A	Small Interfering RNA (siRNA)	Others
Mapk3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Mapk3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mapk3 Rat Pre-designed siRNA Set A Mapk3 Rat Pre-designed siRNA Set A

HY-182382

Anticancer agent 311	Apoptosis MDM-2/p53 Caspase	Cancer
Anticancer agent 311 is an apoptosis inducer and p53 modulator. Anticancer agent 311 increases p53 levels, activates cleaved caspase-3, reduces p-Cdc25C levels, and disrupts p-p44/42 MAPK phosphorylation. Anticancer agent 311 induces G2/M phase arrest, inhibits cancer cell viability in a concentration- and time-dependent manner, and exhibits low toxicity to non-cancer cells. Anticancer agent 311 prevents tumor growth and angiogenesis in mouse xenograft models without detectable toxicity. Anticancer agent 311 can be used for the research of lung cancer .

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P701678

	ERK1 Protein, Human (Active, GST) MAPK3; Mitogen-activated protein kinase 3; MAP kinase 3; MAPK 3; ERT2; Extracellular signal-regulated kinase 1; ERK-1; Insulin-stimulated MAP2 kinase; MAP kinase isoform p44; p44-MAPK; Microtubule-associated protein 2 kinase; p44-ERK1	Human	E. coli
	ERK1 protein is an important serine/threonine kinase in the MAP kinase pathway and cooperates with MAPK1/ERK2 to activate the MAPK/ERK cascade. Stimulated by KIT and KITLG/SCF, this pathway plays a key role in cell growth, adhesion, survival, and differentiation. ERK1 Protein, Human (GST) is the recombinant human-derived ERK1 protein, expressed by E. coli , with N-GST labeled tag.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Host:	Mouse (6) Rabbit (7)
Reactivity:	Human (13) Rat (10) Mouse (13) Monkey (2)
Application:	IHC-P (9) ICC/IF (10) IF-Tissue (4) IP (4) IHC-F (4) WB (13) FC (8) ELISA (6)
Isotype:	IgG (9) IgG1 (3)
Conjugation:	Non-conjugated (13)
Clonality:	Polyclonal (1) Monoclonal (8) Monoclonal Antibody (1) Recombinant (2)
Modification:	Phosphorylated (3) Unmodified (7)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P86742

	ERK1/2 Antibody (YA6434) ERK; ERK-1; ERT 2; ERT2; Extracellular Signal Regulated Kinase 1; Extracellular signal related kinase 1; Extracellular signal-regulated kinase 1; HGNC6877; HS44KDAP; HUMKER1A; Insulin Stimulated MAP2 Kinase; Insulin-stimulated MAP2 kinase; MAP kinase 1; MAP kinase 3; MAP Kinase; MAP kinase isoform p44; MAPK 1; MAPK 3; MAPK; MAPK1; MAPK3; MGC20180; Microtubule Associated Protein 2 Kinase; Microtubule-associated protein 2 kinase; Mitogen Activated Protein Kinase 3; Mitogen-activated protein kinase 1; Mitogen-activated protein kinase 3; MK03_HUMAN; OTTHUMP00000174538; OTTHUMP00000174541; p44 ERK1; p44 MAPK; p44-ERK1; p44-MAPK; p44ERK1; p44MAPK; PRKM 3; PRKM3; Protein Kinase Mitogen Activated 3.	WB, IHC-P, IHC-F, IF-Tissue, FC	Human, Mouse, Rat
	ERK1/2 Antibody (YA6434) is a Mouse-derived and non-conjugated IgG monoclonal antibody, targeting to ERK1/2.

HY-P86742A

	ERK1/2 Antibody (YA6434)(PBS only) ERK; ERK-1; ERT 2; ERT2; Extracellular Signal Regulated Kinase 1; Extracellular signal related kinase 1; Extracellular signal-regulated kinase 1; HGNC6877; HS44KDAP; HUMKER1A; Insulin Stimulated MAP2 Kinase; Insulin-stimulated MAP2 kinase; MAP kinase 1; MAP kinase 3; MAP Kinase; MAP kinase isoform p44; MAPK 1; MAPK 3; MAPK; MAPK1; MAPK3; MGC20180; Microtubule Associated Protein 2 Kinase; Microtubule-associated protein 2 kinase; Mitogen Activated Protein Kinase 3; Mitogen-activated protein kinase 1; Mitogen-activated protein kinase 3; MK03_HUMAN; OTTHUMP00000174538; OTTHUMP00000174541; p44 ERK1; p44 MAPK; p44-ERK1; p44-MAPK; p44ERK1; p44MAPK; PRKM 3; PRKM3; Protein Kinase Mitogen Activated 3.	WB, IHC-P, IHC-F, IF-Tissue, FC	Human, Mouse, Rat
	ERK1/2 Antibody (YA6434) is a Mouse-derived and non-conjugated IgG monoclonal antibody, targeting to ERK1/2.

HY-P86387

	ERK1/2 Antibody (YA6079) MAPK3; ERK1; PRKM3; Mitogen-activated protein kinase 3; MAP kinase 3; MAPK 3; ERT2; Extracellular signal-regulated kinase 1; ERK-1; Insulin-stimulated MAP2 kinase; MAP kinase isoform p44; p44-MAPK; Microtubule-associated protein 2 kinase; p	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	ERK1/2 Antibody (YA6079) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to ERK1/2.

HY-P86225

	Phospho-Erk 1/2(Thr202/Tyr204) Antibody (YA5917) MAPK3; ERK1; PRKM3; Mitogen-activated protein kinase 3; MAP kinase 3; MAPK 3; ERT2; Extracellular signal-regulated kinase 1; ERK-1; Insulin-stimulated MAP2 kinase; MAP kinase isoform p44; p44-MAPK; Microtubule-associated protein 2 kinase; p	WB, ICC/IF, IP, ELISA	Human, Mouse, Rat
	Phospho-Erk 1/2(Thr202/Tyr204) Antibody (YA5917) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-Erk 1/2(Thr202/Tyr204).

HY-P85839

	ERK1 Antibody (YA5531) ERK1; ERT2; ERK-1; PRKM3; p44ERK1; p44MAPK; HS44KDAP; HUMKER1A; p44-ERK1; p44-MAPK	WB, ICC/IF, ELISA	Human, Mouse, Rat
	ERK1 Antibody (YA5531) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to ERK1.

HY-P86654

	ERK1/2 Antibody (YA6346) ERK1+ERK2; ERK 1; ERK 2; ERK-2; ERK1; ERK2; ERT1; ERT2; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 2; Extracellular signal-regulated kinase 2; HS44KDAP; HUMKER1A; Insulin stimulated MAP2 kinase; MAP kinase 1; MAP kinase 2; MAP kinase isoform p42; MAP kinase isoform p44; MAPK 1; MAPK 2; MAPK 3; MAPK1; MAPK2; MAPK3; MGC20180; Microtubule associated protein 2 kinase; Mitogen activated protein kinase 1; Mitogen activated protein kinase 2; Mitogen activated protein kinase 3; Mitogen-activated protein kinase 1; Mitogen-activated protein kinase 2; MK01_HUMAN; MK03_HUMAN; p38; p40; p41; p41MAPK; p42 MAPK; p42-MAPK; p42MAPK; p44 ERK1; p44 MAPK; p44ERK1; p44MAPK; PRKM 1; PRKM 2; PRKM 3; PRKM1; PRKM2; PRKM3; Protein kinase mitogen activated 1; Protein kinase mitogen activated 2; Protein kinase mitogen activated 3; Protein tyrosine kinase ERK 2.	WB, IHC-P, IHC-F, ICC/IF, IF-Tissue, FC	Human, Mouse, Rat
	ERK1/2 Antibody (YA6346) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to ERK1/2.

HY-P80393

	ERK1/2 Antibody (YA453) 4 Publications Verification MAP kinase 3; MAPK 3; ERK-1; p44-MAPK; MAP kinase 1; MAPK 1; ERK-2; p42-MAPK	WB, ICC/IF, IP, FC	Human, Mouse, Rat
	ERK1/2 Antibody (YA453) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to ERK1/2.

HY-P84224

	ERK1 Antibody (YA3921) ERK1; PRKM3; p44ERK1; p44MAPK; HS44KDAP; HUMKER1A; MGC20180	WB, IHC-P, ICC/IF, FC, ELISA	Human, Mouse, Rat, Monkey
	ERK1 Antibody (YA3921) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to ERK1.

HY-P84224A

	ERK1 Antibody (YA3921)(PBS only) ERK1; PRKM3; p44ERK1; p44MAPK; HS44KDAP; HUMKER1A; MGC20180	WB, IHC-P, ICC/IF, FC, ELISA	Human, Mouse, Rat, Monkey
	ERK1 Antibody (YA3921) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to ERK1.

HY-P810604

	Phospho-Erk1 (Thr202)+Erk2 (Thr185) Antibody (YA9866) ERK1; PRKM3; p44ERK1; p44MAPK; HS44KDAP; HUMKER1A; MGC20180	WB, ICC/IF, IHC-P, FC, IF-Tissue	Human, Mouse, Rat
	Phospho-Erk1 (Thr202)+Erk2 (Thr185) Antibody (YA9866) is a Rabbit-derived and non-conjugated IgG Recombinant, Monoclonal antibody, targeting to Phospho-Erk1 (Thr202)+Erk2 (Thr185).

HY-P81156

	phospho-ERK1 + 2 (Thr183/Tyr185) Antibody ERK1 + ERK2 (phospho Thr183/Tyr185); phospho-ERK1/MAPK-1/2(Thr183/Tyr185); ERK 1; ERK 2; ERK-2; ERK1; ERK2; ERT1; ERT2; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 2; Extracellular signal regulated kinase 2; Extracellular signal-regulated kinase 2; HS44KDAP; HUMKER1A; Insulin stimulated MAP2 kinase; MAP kinase 1; MAP kinase 2; MAP kinase isoform p42;	WB, ELISA, IHC-P, IHC-F, ICC/IF	Human, Mouse
	phospho-ERK1 + 2 (Thr183/Tyr185) Antibody is a Rabbit-derived and non-conjugated IgG polyclonal antibody, targeting to phospho-ERK1 + 2 (Thr183/Tyr185).

HY-P85629

	Phospho-ERK1/2(Thr202/Tyr204) Antibody (YA5321) ERK 1; ERK 2; ERK-2; ERK1; erk1/2; ERK2; ERT1; ERT2; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 1	WB	Human, Mouse
	Phospho-ERK1/2(Thr202/Tyr204) Antibody (YA5321) is a Mouse-derived and non-conjugated monoclonal antibody, targeting to Phospho-ERK1/2(Erk1/2)(Thr202/Tyr204).

HY-P80391

	ERK1 Antibody (YA454)	WB, ICC/IF, IHC-P, IP, FC	Human, Mouse
	ERK1 Antibody (YA454) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to ERK1.

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Host
Reactivity
Application
Dilution Ratio
Molecular Weight
Conjugation
Clonality
Immunogen
Appearance
Isotype
Gene ID
SwissProt ID
Purity
Formulation
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

MAPK3 Human Pre-designed siRNA Set A		siRNAs Human Pre-designed siRNA Sets
MAPK3 Human Pre-designed siRNA Set A contains three designed siRNAs for MAPK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mapk3 Mouse Pre-designed siRNA Set A		siRNAs Mouse Pre-designed siRNA Sets
Mapk3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mapk3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Mapk3 Rat Pre-designed siRNA Set A		siRNAs Rat Pre-designed siRNA Sets
Mapk3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Mapk3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

Inquiry Online

Your information is safe with us. * Required Fields.

MCE Japan Authorized Agent ナミキ商事株式会社コスモ・バイオ株式会社重松貿易株式会社
Salutation			Country or Region *
Applicant Name *			Organization Name *
Department *
Email Address *			Product Name *
Cat. No.			Requested quantity *
Phone Number *
Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: